Research Article

A Novel Strategy for Screening Active Components in Cistanche tubulosa Based on Spectrum-Effect Relationship Analysis and Network Pharmacology

Table 4

Correlation coefficients of PLSR and BCA models for the peak area and antioxidant assay.

GroupsPeaksDPPH
PLSRRanksBCARanksPLSRRanksBCARanksPLSRRanksBCARanks

HA10.20420.60210.28820.6451−0.413110.0702
A20.05840.03640.12230.1544−0.0962−0.1334
A30.28210.41820.38710.5882−0.3199−0.1113
A4−0.0847−0.58611−0.0379−0.4359−0.1123−0.5707
A5−0.0696−0.5648−0.0127−0.3997−0.1715−0.6098
A6−0.11290.33430.02250.3453−0.25770.1621
A7−0.12410−0.57490.0076−0.3586−0.2176−0.6149
A80.0693−0.41850.0294−0.3435−0.1484−0.5336
A9−0.14811−0.58310−0.06411−0.44110−0.32110−0.66910
A10−0.0928−0.5596−0.0228−0.4078−0.0791−0.5015
A11−0.0595−0.5637−0.04710−0.45011−0.3008−0.70211

WEA10.24640.08920.33120.5712−0.23111−0.4237
A2−0.5789−0.2207−0.12411−0.1488−0.0291−0.2892
A3−0.66611−0.1976−0.04480.0234−0.0996−0.3653
A40.8071−0.07630.11240.0135−0.1087−0.55810
A50.6442−0.10240.12730.0533−0.12710−0.59311
A60.11450.11510.34310.6051−0.0985−0.1371
A70.2743−0.15750.0096−0.0727−0.1208−0.5579
A8−0.4018−0.31510−0.0739−0.25810−0.0403−0.3664
A9−0.1846−0.24480.0655−0.0456−0.1259−0.4718
A10−0.62610−0.35711−0.10310−0.28211−0.0444−0.3755
A11−0.3427−0.3079−0.0307−0.1999−0.0382−0.3776

HRA1−0.24910−0.0492−0.10270.1993−0.251100.0532
A2−0.1869−0.36950.0232−0.1074−0.0875−0.2764
A3−0.32311−0.27530.06010.2562−0.28311−0.1343
A4−0.1588−0.53311−0.21511−0.68811−0.2019−0.68911
A5−0.1367−0.51810−0.1649−0.64710−0.1868−0.68310
A60.17010.4301−0.01730.28710.18010.4991
A7−0.0905−0.4308−0.17210−0.6149−0.1836−0.6328
A8−0.0684−0.3997−0.0486−0.5137−0.0434−0.4997
A9−0.1286−0.4669−0.1178−0.5998−0.1847−0.6459
A10−0.0282−0.3604−0.0465−0.5096−0.0383−0.4956
A11−0.0523−0.3706−0.0354−0.4915−0.0312−0.4735